RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MARINO D
Collezione AO Ordine Mauriziano

Items : 13

First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies. in American journal of hematology / Am J Hematol. 2025 Jan;100(1):189-191. doi: 10.1002/ajh.27524. Epub 2024 Nov 19.

2025
AO Ordine Mauriziano

Autore F; Tedeschi A; Benevolo G; Mattiello V; Galli E; Danesin N; Rizzi R; Olivieri J; Cencini E; Puccini B; Ferrarini I; Marino D; Bullo M; Rossini B; Motta M; Innocenti I; Fresa A; Stirparo L; Petrilli D; Pasquale R; Musto P; Scapinello G; Noto A; Peri V; Zamprogna G; Hohaus S; Frustaci AM; Piazza F; Ferrero S; et alii...

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial. in ESMO open / ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27.

2025
AO Ordine Mauriziano

Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2023 Dec 1;9(12):1651-1659. doi: 10.1001/jamaoncol.2023.4003.

2023
AO Ordine Mauriziano

Qin S; Kudo M; Meyer T; Bai Y; Guo Y; Meng Z; Satoh T; Marino D; Assenat E; Li S; Chen Y; Boisserie F; Abdrashitov R; Finn RS; Vogel A; Zhu AX;

Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy. in Seizure / Seizure. 2021 Mar;86:70-76. doi: 10.1016/j.seizure.2021.01.014. Epub 2021 Jan 30.

2021
AO Ordine Mauriziano

Lazzaretti D; Lazzari M; Kiferle L; Guadagni M; Florindo I; Di Claudio MT; Cottone S; Contento M; Cavalli SM; Meletti S; Giovannini G; Strigaro G; Rum A; Rosati E; Renna R; Piccioli M; Marino D; Ferlisi M; Gaudio LD; Dono F; Nazerian P; Pescini F; Beretta S; Dainese F; Giordano A; Zummo L; Cappellani R; Zinno L; Nilo A; et alii...

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? in Exploration of targeted anti-tumor therapy / Explor Target Antitumor Ther. 2021;2(5):448-464. doi: 10.37349/etat.2021.00056. Epub 2021 Oct 31.

2021
AO Ordine Mauriziano

Di Maio M; De Vita F; Gamba T; Caglio A; Sperti E; Marino D; Zichi C; Paratore C; Aimar G;

Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.

2020
AO Ordine Mauriziano

Marino D; Baratelli C; Guida G; Turco CGC; Lacidogna G; Sperti E; Vignani F; De Luca E; Zichi C; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Corrigendum to ""Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer" [Crit. Rev. Oncol. Hematol. 133 (January) (2019) 17-24]. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102867. doi: 10.1016/j.critrevonc.2020.102867. Epub 2020 Feb 12

2020
ASL Alessandria
AO Ordine Mauriziano

Aglietta M; Campra D; De Paolis P; Santarelli M; Marino D; Silvestri S; Lombardi P; Leone F;

Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence. in Cancer management and research / Cancer Manag Res. 2020 May 20;12:3721-3729. doi: 10.2147/CMAR.S216220. eCollection 2020.

2020
AO Ordine Mauriziano

De Luca E; Marino D; Di Maio M;

"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jan;133:17-24. doi: 10.1016/j.critrevonc.2018.10.009. Epub 2018 Nov 2.

2019
ASL Alessandria
AO Ordine Mauriziano

Aglietta M; Campra D; De Paolis P; Santarelli M; Marino D; Silvestri S; Lombardi P; Leone F;

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.

2019
AO Ordine Mauriziano

Baratelli C; Turco CGC; Lacidogna G; Sperti E; Vignani F; Marino D; Zichi C; De Luca E; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Polimeno L; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Second-line treatment options in hepatocellular carcinoma. in Drugs in context / Drugs Context. 2019 Apr 10;8:212577. doi: 10.7573/dic.212577. eCollection 2019.

2019
AO Ordine Mauriziano

Marino D; Zichi C; Audisio M; Sperti E; Di Maio M;

Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2014 Dec;92(3):218-26. doi: 10.1016/j.critrevonc.2014.05.010. Epub 2014 Jun

2014
AO Ordine Mauriziano

Marino D; Leone F; D'Avanzo F; Ribero D; Capussotti L; Aglietta M;

Targeted agents: how can we improve the outcome in biliary tract cancer? in Hepatobiliary surgery and nutrition / Hepatobiliary Surg Nutr. 2013 Feb;2(1):31-3. doi: 10.3978/j.issn.2304-3881.2012.09.03.

2013
AO Ordine Mauriziano

Marino D; Colombi F; Ribero D; Aglietta M; Leone F;